Details for: GEN-CLOZAPINE
Company: MYLAN PHARMACEUTICALS ULC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02247243 | GEN-CLOZAPINE | CLOZAPINE | 25 MG | TABLET | ORAL |
| 02305003 | GEN-CLOZAPINE | CLOZAPINE | 50 MG | TABLET | ORAL |
| 02247244 | GEN-CLOZAPINE | CLOZAPINE | 100 MG | TABLET | ORAL |
| 02305011 | GEN-CLOZAPINE | CLOZAPINE | 200 MG | TABLET | ORAL |
Summary Reports
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Sleep Apnoea
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - SurgiWrap Adhesion Barrier Film - Assessing the potential risk of foreign body reactions that mimic local re-appearance of cancer
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Summary Safety Review - Clozapine - Assessing the effectiveness of monitoring for low numbers of white blood cells
Summary Safety Review - Atypical antipsychotics - Assessing the Potential Risk of Urinary Retention
Summary Safety Review - Atypical Antipsychotics - Liver failure
Summary Safety Review - SurgiWrap Adhesion Barrier Film - Assessing the potential risk of foreign body reactions that mimic local re-appearance of cancer
Summary Safety Review - Atypical antipsychotics - Assessing the potential risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
Summary Safety Review - Clozapine - Assessing the effectiveness of monitoring for low numbers of white blood cells
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.